Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancers|June 4, 2020
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic OpportunitiesAlice Turdo, Gaetana Porcelli, Caterina D'Accardo, et al.
Frontiers in Endocrinology|August 10, 2016
Prognostic Factors for Adrenocortical Carcinoma OutcomesClaudia Scollo, Marco Russo, Maria Antonietta Trovato, et al.
Lung Cancer (Amsterdam, Netherlands)|January 13, 2006
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)Carmelo Giannitto Giorgio, Alessandro Pappalardo, Antonio Russo, et al.
Case Reports in Endocrinology|June 16, 2025
Severe Late-Onset Abiraterone-Induced Hypokalemia in a Diabetic Patient With Concomitant Adrenal Gland Incidentaloma: A Diagnostic ChallengeAndrea Tumminia, Francesco Galeano, Vittorio Oteri, et al.
RSC Advances|February 10, 2023
Improved chemometric approach for XRF data treatment: application to the reverse glass paintings from the Lipari collectionFrancesco Armetta, Maria Luisa Saladino, Maria Clara Martinelli, et al.
Frontiers in Endocrinology|September 28, 2020
Cancer Stem Cells in Thyroid Tumors: From the Origin to MetastasisVeronica Veschi, Francesco Verona, Melania Lo Iacono, et al.
International Journal of Molecular Sciences|December 23, 2022
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer ManagementAlessia Filippone, Deborah Mannino, Giovanna Casili, et al.
Oncology|November 12, 2005
Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancerGiorgio Carmelo Giannitto, Dario Giuffrida, Alessandro Pappalardo, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804Francesca Lombardo, Eric Baudin, Eusebio Chiefari, et al.
Pageof 7